Davis Selected Advisers’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-385,539
Closed -$100M 109
2025
Q3
$100M Sell
385,539
-1,267,195
-77% -$333M 0.52% 38
2025
Q2
$404M Sell
1,652,734
-678,609
-29% -$169M 2.16% 17
2025
Q1
$617M Buy
2,331,343
+74,434
+3% +$20.1M 3.56% 10
2024
Q4
$573M Sell
2,256,909
-52,648
-2% -$14.1M 3.33% 11
2024
Q3
$732M Sell
2,309,557
-1,805
-0.1% -$643K 4.1% 8
2024
Q2
$864M Buy
2,311,362
+321,233
+16% +$108M 5.02% 7
2024
Q1
$690M Buy
1,990,129
+1,946,566
+4,468% +$738M 3.87% 7
2023
Q4
$19.9M Sell
43,563
-1
-0% -$493 0.11% 54
2023
Q3
$21.2M Sell
43,564
-25
-0.1% -$11.7K 0.13% 49
2023
Q2
$19.5M Buy
43,589
+21
+0% +$10.6K 0.12% 50
2023
Q1
$21.2M Buy
43,568
+132
+0.3% +$65.3K 0.14% 49
2022
Q4
$22.2M Sell
43,436
-65
-0.1% -$34.2K 0.15% 48
2022
Q3
$21.1M Sell
43,501
-311
-0.7% -$151K 0.15% 47
2022
Q2
$20.5M Sell
43,812
-13
-0% -$5.78K 0.13% 49
2022
Q1
$19.1M Sell
43,825
-1,140
-3% -$477K 0.1% 64
2021
Q4
$20.9M Sell
44,965
-346
-0.8% -$153K 0.1% 68
2021
Q3
$17.6M Sell
45,311
-511
-1% -$217K 0.08% 68
2021
Q2
$20.3M Sell
45,822
-17,741
-28% -$7.75M 0.08% 66
2021
Q1
$26.6M Buy
63,563
+12
+0% +$4.79K 0.12% 52
2020
Q4
$26.1M Buy
63,551
+742
+1% +$309K 0.13% 48
2020
Q3
$26M Sell
62,809
-1,018
-2% -$409K 0.14% 46
2020
Q2
$24.7M Sell
63,827
-9,796
-13% -$3.67M 0.14% 48
2020
Q1
$23.1M Sell
73,623
-55,561
-43% -$18.7M 0.16% 54
2019
Q4
$47.3M Sell
129,184
-5,082
-4% -$1.61M 0.23% 43
2019
Q3
$34.3M Buy
134,266
+306
+0.2% +$85.8K 0.17% 49
2019
Q2
$35.5M Buy
+133,960
New +$34M 0.18% 51

Other funds holding HUM

Davis Selected Advisers's HUM Position: Q4 2025 in Review

Davis Selected Advisers sold out of Humana (HUM) in Q4 2025, closing a stake of 385,539 shares — an estimated $100M sold.

Davis Selected Advisers first reported a position in HUM in Q2 2019 and held it in 26 quarters. The position peaked at $864M in Q2 2024. 862 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • Davis Selected Advisers reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
  • Davis Selected Advisers sold 385,539 Humana shares in Q4 2025, an estimated $100M.
  • Davis Selected Advisers first reported a position in Humana in Q2 2019 and held it in 26 quarters.
  • Davis Selected Advisers's Humana position peaked at $864M in Q2 2024.
  • 862 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on Davis Selected Advisers's 13F filing for Q4 2025, filed 2 Feb 2026.